BioWorld MedTech

May 27, 2010

Compelling in registry results clinch clinical case for TAVI

PARIS – Transcatheter aortic valve implants (TAVI) have experienced a rapid take-up in Europe since the procedure was introduced in 2007. {Medical Device Daily} Read More

Docs weigh in on outlook for innovation & medical practice

Shuren takes aim at change of culture for Center for Devices

Survey: lawsuit fears hinder adoption of new med-tech

Report from Europe: Volcano wins CE mark for vascular imaging catheter

MDD's food for med tech thought

Deals roundup: Covidien to shed Specialty Chemicals for $280M in cash

People in the News

Patent watch: Applied Spine gets two patents expanding Stabilimax portfolio

Med-Tech's Next Great Opportunity: Obesity

Product Briefs

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for July 16, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for July 16, 2025.

Atai Therapeutics discovers new 5-HT2A receptor partial agonists

BioWorld Science

Atai Therapeutics Inc. has synthesized new tetrahydro pyridine-substituted indole and azaindoles acting as 5-HT2A receptor partial agonists reported to be useful...

PHD inhibitors reported in Akebia Therapeutics patent

BioWorld Science

Akebia Therapeutics Inc. has identified new derivatives of ([1,2,4]triazolo[5,1-a]isoquinoline-5-carbonyl)glycinate acting as prolyl 4-hydroxylase (PHD) inhibitors.

Woman in military clothing talking with psychologist

FDA wants more data for Otsuka’s sNDA in PTSD

BioWorld

The U.S. FDA is insisting that another study is needed to bolster the sNDA for Rexulti (brexpiprazole) from Otsuka Pharmaceutical Co. Ltd. in treating adults with...